Abstract
We combined information published worldwide on the seroprevalence of hepatitis B surface antigen (HbsAg) and antibodies against hepatitis C virus (anti-HCV) in 27 881 hepatocellular carcinomas (HCCs) from 90 studies. A predominance of HBsAg was found in HCCs from most Asian, African and Latin American countries, but anti-HCV predominated in Japan, Pakistan, Mongolia and Egypt. Anti-HCV was found more often than HBsAg in Europe and the United States.
Publication types
-
Meta-Analysis
-
Research Support, Non-U.S. Gov't
-
Systematic Review
MeSH terms
-
Carcinoma, Hepatocellular / epidemiology
-
Carcinoma, Hepatocellular / immunology
-
Carcinoma, Hepatocellular / virology*
-
Global Health
-
Hepacivirus / immunology*
-
Hepatitis B / epidemiology
-
Hepatitis B / immunology*
-
Hepatitis B Surface Antigens / blood
-
Hepatitis B virus / immunology*
-
Hepatitis C / epidemiology
-
Hepatitis C / immunology*
-
Hepatitis C Antibodies / blood
-
Humans
-
Liver Neoplasms / epidemiology
-
Liver Neoplasms / immunology
-
Liver Neoplasms / virology*
-
Seroepidemiologic Studies
Substances
-
Hepatitis B Surface Antigens
-
Hepatitis C Antibodies